Nabla
Ambient AI documentation and agentic clinical-workflow platform used by roughly 85,000 clinicians across 130+ healthcare organizations, strong in Europe and the US.
This is where the depth lives — everything below is evidence-graded
How the product is positioned
Ambient AI documentation and agentic clinical-workflow platform used by roughly 85,000 clinicians across 130+ healthcare organizations, strong in Europe and the US.
Our summary of the vendor’s positioning — verbatim claim not yet recordedWhat we found
Level 2 · augmentative
Completes the unit of work end to end without a person producing it, but a licensed clinician must review and attest to the note before it enters the medical record. That checkpoint is imposed from outside the product, not configured within it.
The human checkpoint here is imposed by regulation — it is not a setting that can be turned off.
Graded 2026-08-01 · re-check 2026-11-01
Procurement detail
- Deployment
- saasvendor documentation
- Compliance
- HIPAA · SOC 2 Type IIreport dates not disclosed — request before signing
- Integrations
- Oracle Health/Cerner claim unverifiedEpic claim unverifiedvarious EHRs via APIs claim unverified
- Pricing
- per-seatNot publicly listed.
- Human checkpoint
- Requiredregulatory, not configurable
- Named customers
- Aultman Health Systemfrom cited sources
Will they still be here?
- Funding
- $70M Series C (June 2025) led by HV Capital; reported ~$5.3B ecosystem valuation context via AMI partnership investment
- Founded
- 2018
- HQ
- Paris, France / New York, USA
Sources
Logo retrieved 2026-08-01from the vendor’s own site · trademark of Nabla Inc.
- statnews.comIndependent · retrieved 2026-08-01
- fiercehealthcare.comIndependent · retrieved 2026-08-01
Where it’s weak
Smaller US health-system penetration than Abridge or Nuance DAX at large academic medical centers.
Corrections
Vendors may submit factual corrections free of charge. We correct facts and publish the change. We do not accept payment to change a grade. Submit a correction →